Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -107.80%-111K | -56.28%188K | 235.44%2.68M | 123.29%827K | 37.57%952K | 156.63%1.42M | -84.98%430K | 56.93%-1.98M | 16.17%-3.55M | -46.48%692K |
| Net income from continuing operations | 22.21%-1.1M | 857.58%1M | -3.55%-2.04M | -2.96%-8.46M | 28.86%-4.94M | 39.88%-1.41M | -160.55%-132K | -328.24%-1.97M | 35.11%-8.22M | -1,550.12%-6.95M |
| Operating gains losses | 152.31%634K | 179.87%250K | 499.35%619K | -423.12%-2.36M | -137.93%-682K | -99.67%-1.21M | 57.18%-313K | -157.20%-155K | -71.80%731K | -18.16%1.8M |
| Depreciation and amortization | -16.69%559K | -5.53%581K | -12.27%608K | -30.09%2.71M | -46.22%655K | 154.17%671K | -44.89%615K | -46.03%693K | -50.72%3.88M | 1,227.78%1.22M |
| Asset impairment expenditure | ---- | ---- | ---- | 177.74%2.61M | ---- | ---- | ---- | ---- | ---3.36M | ---- |
| Remuneration paid in stock | ---193K | ---- | ---- | 412.53%2M | --2M | --0 | ---- | ---- | --391K | ---- |
| Remuneration paid in stock | -48.14%167K | 195.56%1.27M | -35.93%403K | -25.43%1.69M | -69.55%310K | 44.39%322K | 292.66%428K | -31.26%629K | 64.73%2.27M | 185.15%1.02M |
| Deferred tax | -181.75%-112K | -29.85%235K | -165.63%-42K | 521.23%907K | 277.51%371K | 661.11%137K | 12.42%335K | 64.10%64K | 44.55%146K | -150.48%-209K |
| Other non cashItems | -36.37%733K | -21.29%747K | -42.41%497K | 115.26%4.56M | -54.86%1.67M | 1,063.64%1.15M | 375.07%949K | 164.40%863K | -25.20%2.12M | 818.61%3.7M |
| Change In working capital | -109.75%-250K | -343.65%-3.11M | 298.99%3.15M | -94.60%161K | -102.26%-120K | 2,209.91%2.56M | -121.22%-701K | 72.45%-1.58M | 181.80%2.98M | 742.44%5.31M |
| -Change in receivables | 221.48%1.48M | -375.54%-1.79M | 156.75%3.55M | -171.06%-5.41M | -102.76%-256K | -51.52%461K | 126.13%650K | -4,310.56%-6.26M | 1,698.95%7.61M | 2,176.96%9.29M |
| -Change in inventory | -224.05%-196K | 101.12%1.26M | -91.52%117K | 220.77%2.26M | -94.01%98K | 111.62%158K | 57.54%627K | 154.14%1.38M | 40.67%-1.87M | 77.63%1.64M |
| -Change in payables and accrued expense | -370.18%-1.39M | -64.01%-3.31M | -104.46%-150K | 182.16%1.74M | 98.47%-121K | 134.25%513K | -131.90%-2.02M | 549.40%3.37M | -295.84%-2.12M | -298.39%-7.91M |
| -Change in other current assets | -110.47%-150K | 1,766.67%728K | -482.81%-373K | 346.61%1.57M | -93.08%159K | 375.75%1.43M | 104.19%39K | 97.22%-64K | 42.11%-635K | 1,452.35%2.3M |
| Interest paid (cash flow from operating activities) | 28.76%-369K | -5.67%-727K | 7.14%-481K | 37.25%-2.48M | 58.27%-752K | -92.57%-518K | 35.03%-688K | 36.52%-518K | -46.15%-3.95M | -101.79%-1.8M |
| Tax refund paid | 35.48%-180K | 15.87%-53K | ---31K | 6.03%-514K | 60.37%-172K | ---279K | -36.96%-63K | --0 | ---547K | -353.80%-434K |
| Cash from discontinued investing activities | 0 | 0 | 0 | 89.70%-363K | 374.90%690K | 78.70%193K | 93.42%-543K | -114.44%-703K | -188.70%-3.53M | -251K |
| Operating cash flow | -106.87%-111K | 266.37%188K | 199.93%2.68M | 106.56%464K | 272.34%1.64M | 167.19%1.62M | 97.90%-113K | -1,071.38%-2.68M | -29.67%-7.08M | 512.50%441K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 72.34%-13K | -420.00%-26K | 98.36%-1K | -315.15%-137K | -109.49%-24K | 12.96%-47K | 96.89%-5K | 14.08%-61K | 97.94%-33K | 394.19%253K |
| Net PPE purchase and sale | 72.34%-13K | -420.00%-26K | 98.36%-1K | 49.82%-137K | -284.62%-24K | 12.96%-47K | 96.89%-5K | 14.08%-61K | 82.98%-273K | 115.12%13K |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --240K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 72.34%-13K | -420.00%-26K | 98.36%-1K | -315.15%-137K | -109.49%-24K | 12.96%-47K | 96.89%-5K | 14.08%-61K | 97.94%-33K | 394.19%253K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 274.33%1.04M | -720.30%-1.65M | -671.38%-1.74M | -111.08%-566K | -224.14%-540K | -39.58%-596K | -93.96%266K | -56.26%304K | 181.69%5.11M | 237.21%435K |
| Net issuance payments of debt | -103.19%-1.21M | -720.30%-1.65M | -671.38%-1.74M | 95.04%-566K | 95.83%-540K | -39.58%-596K | -79.32%266K | -56.26%304K | -82.28%-11.4M | -10,141.86%-12.95M |
| Net common stock issuance | ---- | ---- | ---- | --0 | --0 | --0 | --0 | ---- | --14.81M | --11.69M |
| Net preferred stock issuance | --2.25M | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --1.7M | ---- |
| Cash from discontinued financing activities | 0 | -262K | ||||||||
| Financing cash flow | 274.33%1.04M | -720.30%-1.65M | -671.38%-1.74M | -111.68%-566K | -412.14%-540K | -39.58%-596K | -93.96%266K | -56.26%304K | 177.50%4.85M | 34.11%173K |
| Net cash flow | ||||||||||
| Beginning cash position | 56.51%4.29M | 112.09%5.96M | 2.10%5.01M | -33.55%4.9M | -13.51%3.7M | -59.41%2.74M | -65.99%2.81M | -33.55%4.9M | -62.49%7.38M | -41.31%4.28M |
| Current changes in cash | -5.96%915K | -1,105.41%-1.49M | 138.60%941K | 89.43%-239K | 24.34%1.08M | 133.71%973K | 112.95%148K | -370.89%-2.44M | 83.01%-2.26M | 653.91%867K |
| Effect of exchange rate changes | 757.14%92K | 15.07%-186K | -95.10%17K | 259.81%342K | 194.21%228K | -103.41%-14K | 40.97%-219K | 2,991.67%347K | -120.98%-214K | -868.00%-242K |
| End cash Position | 43.16%5.3M | 56.51%4.29M | 112.09%5.96M | 2.10%5.01M | 2.10%5.01M | -13.51%3.7M | -59.41%2.74M | -65.99%2.81M | -33.55%4.9M | -33.55%4.9M |
| Free cash from | -107.90%-124K | 237.29%162K | 197.67%2.68M | 104.43%327K | 289.88%1.62M | 163.81%1.57M | 97.89%-118K | -1,437.56%-2.74M | -4.29%-7.39M | 1,331.03%415K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.